{
  "id": 19227183,
  "title": "FDA warns of rare 'eye stroke' risk from GLP-1 drugs",
  "url": "https://urgent.news/2026/11/09/fda-warns-of-rare-eye-stroke-risk-from-glp-1-drugs",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-09T21:33:48.000Z",
  "source": {
    "name": "The Hill",
    "slug": "the-hill",
    "url": "https://thehill.com/policy/healthcare/6209047-fda-glp1-drug-nainon-risk/"
  },
  "original_language": "en",
  "account": null,
  "summary": "The Food and Drug Administration (FDA) on Monday required pharmaceutical companies to warn patients and healthcare providers of a potential increased risk of a serious eye condition associated with the use of GLP-1 drugs for weight loss and diabetes. Non-arteritic anterior ischemic optic neuropathy (NAION), often referred to as an \"eye stroke,” is a rare condition...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 4,
    "also_reported_by": [
      {
        "outlet": "STAT News",
        "title": "STAT+: FDA warns GLP-1 drugs carry potential risk of rare eye condition",
        "url": "https://urgent.news/2026/11/09/stat-fda-warns-glp-1-drugs-carry-potential-risk-of-rare-eye-condition",
        "published": "2026-11-09T15:56:55.000Z"
      },
      {
        "outlet": "Medical Xpress",
        "title": "GLP-1 drugs show lower obesity-related cancer risk than insulin, but not all diabetes treatments",
        "url": "https://urgent.news/2026/11/09/glp-1-drugs-show-lower-obesity-related-cancer-risk-than-insulin-but",
        "published": "2026-11-09T18:20:04.000Z"
      },
      {
        "outlet": "Winnipeg Free Press",
        "title": "FDA adds rare vision-loss warning to popular GLP-1 drugs",
        "url": "https://urgent.news/2026/11/09/fda-adds-rare-vision-loss-warning-to-popular-glp-1-drugs",
        "published": "2026-11-09T20:21:53.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}